Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study

Citation

Doan, T, Fox, G, Meehan, M et al 2019, 'Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study', Journal of Antimicrobial Chemotherapy, vol. 74, pp. 218-227pp.

Year

2019

ANU Authors

Fields of Research

  • Epidemiology
  • Pharmacogenomics
  • Clinical Pharmacology And Therapeutics

Updated:  15 September 2019 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers